breyanzihcp.com | Breyanzi CAR T cell therapy

Robots.txt Information

Robot	Path	Permission
GoogleBot	/	✔
BingBot	/	✔
BaiduSpider	/	✔
YandexBot	/	✔
User-agent: * Sitemap:

Meta Tags

Title	Breyanzi CAR T cell therapy \| For Healthcare
Description	Breyanzi (lisocabtagene maraleucel), a CD19-directed, genetically modified, autologous T cell immunotherapy for adult patients with R/R LBCL after 1L therapy. See response rates, and safety profile. Please see Important Safety Information including
Keywords	N/A

Server Information

WebSite	breyanzihcp.com
Host IP	45.60.170.161
Location	United States

Related Websites

                        Site
                        Rank
                    

More to Explore

breyanzihcp.com Valuation

US$5,605,428

Last updated: 2023-04-30 02:28:51

breyanzihcp.com has Semrush global rank of 1,888,224. breyanzihcp.com has an estimated worth of US$ 5,605,428, based on its estimated Ads revenue. breyanzihcp.com receives approximately 646,781 unique visitors each day. Its web server is located in United States, with IP address 45.60.170.161. According to SiteAdvisor, breyanzihcp.com is safe to visit.

Traffic & Worth Estimates

Purchase/Sale Value	US$5,605,428
Daily Ads Revenue	US$5,175
Monthly Ads Revenue	US$155,228
Yearly Ads Revenue	US$1,862,727
Daily Unique Visitors	43,119
Note: All traffic and earnings values are estimates.

DNS Records

Host	Type	TTL	Data
breyanzihcp.com.	A	298	IP: 45.60.170.161
breyanzihcp.com.	A	298	IP: 45.60.150.161
breyanzihcp.com.	NS	86400	NS Record: ns-1163.awsdns-17.org.
breyanzihcp.com.	NS	86400	NS Record: ns-1652.awsdns-14.co.uk.
breyanzihcp.com.	NS	86400	NS Record: ns-376.awsdns-47.com.
breyanzihcp.com.	NS	86400	NS Record: ns-668.awsdns-19.net.
breyanzihcp.com.	TXT	300	TXT Record: pwbgql7s851cc1b5bdt6t58xxbl0dym1
breyanzihcp.com.	TXT	300	TXT Record: google-site-verification=ccc5ir3RpHu-6WWHik84pGcH6lPf7aDn7Mk2q162d1Y

HtmlToTextCheckTime:2023-04-30 02:28:51

Indication INDICATION BREYANZI is a CD19-directed genetically modified autologous T cell immunotherapy indicated for the treatment of adult patients with large B-cell lymphoma (LBCL), including diffuse large B-cell lymphoma (DLBCL) not otherwise specified (including DLBCL arising from indolent lymphoma), high-grade B cell lymphoma, primary mediastinal large B-cell lymphoma, and follicular lymphoma grade 3B, who have: refractory disease to first-line chemoimmunotherapy or relapse within 12 months of first-line chemoimmunotherapy; or refractory disease to first-line chemoimmunotherapy or relapse after first-line chemoimmunotherapy and are not eligible for hematopoietic stem cell transplantation (HSCT) due to comorbidities or age; or relapsed or refractory disease after two or more lines of systemic therapy. Limitations of Use : BREYANZI is not indicated for the treatment of patients with primary central nervous system lymphoma. U.S. Full Prescribing Information Prep and Administration

HTTP Headers

HTTP/1.1 301 Moved Permanently
Date: Fri, 22 Oct 2021 22:24:36 GMT
Content-Type: text/html; charset=iso-8859-1
Connection: keep-alive
Set-Cookie: AWSALBTG=tyc9C5Xn4gjCB0YtSxR2OGz5zsv1xg9cEczijOqL3iGeUi+u+unLpOr6VKur0+Ma8bUv47/wkGw5VTU+0VMPpVLSSQmvt/v5xhGKjR2ay9Gvr00rh0TPOicX7EHU75e5nRx5bCZQhMfxlqa2xPm++4ykc/GHZVrMzR+imGrOy3socVLqke8=; Expires=Fri, 29 Oct 2021 22:24:36 GMT; Path=/
Set-Cookie: AWSALBTGCORS=tyc9C5Xn4gjCB0YtSxR2OGz5zsv1xg9cEczijOqL3iGeUi+u+unLpOr6VKur0+Ma8bUv47/wkGw5VTU+0VMPpVLSSQmvt/v5xhGKjR2ay9Gvr00rh0TPOicX7EHU75e5nRx5bCZQhMfxlqa2xPm++4ykc/GHZVrMzR+imGrOy3socVLqke8=; Expires=Fri, 29 Oct 2021 22:24:36 GMT; Path=/; SameSite=None
Server: Apache
Location: https://breyanzihcp.com/
Set-Cookie: AWSALBAPP-0=_remove_; Expires=Fri, 29 Oct 2021 22:24:36 GMT; Path=/
Set-Cookie: AWSALBAPP-1=_remove_; Expires=Fri, 29 Oct 2021 22:24:36 GMT; Path=/
Set-Cookie: AWSALBAPP-2=_remove_; Expires=Fri, 29 Oct 2021 22:24:36 GMT; Path=/
Set-Cookie: AWSALBAPP-3=_remove_; Expires=Fri, 29 Oct 2021 22:24:36 GMT; Path=/
Set-Cookie: visid_incap_2628109=kD75F7edSqKAisrb7T4MPiM6c2EAAAAAQUIPAAAAAABwV1c0aTIVHEiIlVrjIPiI; expires=Sat, 22 Oct 2022 06:08:37 GMT; HttpOnly; path=/; Domain=.breyanzihcp.com
Set-Cookie: incap_ses_210_2628109=najwHu1InjClJ7cSGxLqAiM6c2EAAAAA9Y/aKljHXiy0XxzdJLw0yQ==; path=/; Domain=.breyanzihcp.com
Set-Cookie: ___utmvmsOuEaOaZ=GCJMELvytBx; path=/; Max-Age=900
Set-Cookie: ___utmvasOuEaOaZ=dpbQZKb; path=/; Max-Age=900
Set-Cookie: ___utmvbsOuEaOaZ=NZt
    XFHOKalz: btp; path=/; Max-Age=900
X-CDN: Imperva
X-Iinfo: 1009-44032821-44033192 NNNN CT(40 -1 0) RT(1634941472411 0) q(0 31 31 1) r(32 32) U6

HTTP/2 301 
date: Fri, 22 Oct 2021 22:24:37 GMT
content-type: text/html; charset=UTF-8
set-cookie: AWSALBTG=Ke50VUsfuAT+awAijVFh0awmy6jHyDGWeXNfLdA8BTyWfbbqeqM+1rBMr8KqDwmNcd+MSxHXko2cJEycJy5z1SRqbY+OeQJeTdCo0gDZFxGvClUwI1VctWiuwKXdvf2hm0x/kqQQOkSVx7wAkr/FJ6e5q/eAEV24j5wMbZkJUwT+mqPg8C0=; Expires=Fri, 29 Oct 2021 22:24:37 GMT; Path=/
set-cookie: AWSALBTGCORS=Ke50VUsfuAT+awAijVFh0awmy6jHyDGWeXNfLdA8BTyWfbbqeqM+1rBMr8KqDwmNcd+MSxHXko2cJEycJy5z1SRqbY+OeQJeTdCo0gDZFxGvClUwI1VctWiuwKXdvf2hm0x/kqQQOkSVx7wAkr/FJ6e5q/eAEV24j5wMbZkJUwT+mqPg8C0=; Expires=Fri, 29 Oct 2021 22:24:37 GMT; Path=/; SameSite=None; Secure
server: Apache
expires: Fri, 22 Oct 2021 23:24:37 GMT
cache-control: max-age=3600
x-redirect-by: WordPress
location: https://www.breyanzihcp.com/
x-xss-protection: 1; mode=block
set-cookie: AWSALBAPP-0=_remove_; Expires=Fri, 29 Oct 2021 22:24:37 GMT; Path=/
set-cookie: AWSALBAPP-1=_remove_; Expires=Fri, 29 Oct 2021 22:24:37 GMT; Path=/
set-cookie: AWSALBAPP-2=_remove_; Expires=Fri, 29 Oct 2021 22:24:37 GMT; Path=/
set-cookie: AWSALBAPP-3=_remove_; Expires=Fri, 29 Oct 2021 22:24:37 GMT; Path=/
set-cookie: visid_incap_2628109=RkqMZKntRiu73emJYd31ICQ6c2EAAAAAQUIPAAAAAABjzT9gU5oChv/yoEq9iqxa; expires=Sat, 22 Oct 2022 06:08:37 GMT; HttpOnly; path=/; Domain=.breyanzihcp.com
set-cookie: incap_ses_210_2628109=OeSpVaOVkF2sKbcSGxLqAiQ6c2EAAAAAFt5dPby8UJ0JNYfo2daVFg==; path=/; Domain=.breyanzihcp.com
x-cdn: Imperva
x-iinfo: 1011-59526761-59526762 NNNN CT(77 74 0) RT(1634941475986 0) q(0 0 2 -1) r(5 5) U6

HTTP/2 200 
date: Fri, 22 Oct 2021 22:24:38 GMT
content-type: text/html; charset=UTF-8
set-cookie: AWSALBTG=z9vx9h2fkMRhM3pOMM3l5zUIRKvLr439un8jcrnzR5dgolBYD9HXRSWiNge2YFRhvOlZKozu6Dmj7ZvIfDVHJVZGf+wgrajvXHWfklIGl6Bc/4SQ6MEAvk3EemB44n7DKuCoIxHdqwsfFJx1tFQCJ9h+nn6EnP7+5tad8q6gRG1Dlt9arZI=; Expires=Fri, 29 Oct 2021 22:24:37 GMT; Path=/
set-cookie: AWSALBTGCORS=z9vx9h2fkMRhM3pOMM3l5zUIRKvLr439un8jcrnzR5dgolBYD9HXRSWiNge2YFRhvOlZKozu6Dmj7ZvIfDVHJVZGf+wgrajvXHWfklIGl6Bc/4SQ6MEAvk3EemB44n7DKuCoIxHdqwsfFJx1tFQCJ9h+nn6EnP7+5tad8q6gRG1Dlt9arZI=; Expires=Fri, 29 Oct 2021 22:24:37 GMT; Path=/; SameSite=None; Secure
server: Apache
link: ; rel=shortlink
x-xss-protection: 1; mode=block
set-cookie: AWSALBAPP-0=_remove_; Expires=Fri, 29 Oct 2021 22:24:38 GMT; Path=/
set-cookie: AWSALBAPP-1=_remove_; Expires=Fri, 29 Oct 2021 22:24:38 GMT; Path=/
set-cookie: AWSALBAPP-2=_remove_; Expires=Fri, 29 Oct 2021 22:24:38 GMT; Path=/
set-cookie: AWSALBAPP-3=_remove_; Expires=Fri, 29 Oct 2021 22:24:38 GMT; Path=/
set-cookie: visid_incap_2628109=iWK8YmA8TDGkhjjUaD/lOyQ6c2EAAAAAQUIPAAAAAADoV5wEm4LzpKQy45qVMGkN; expires=Sat, 22 Oct 2022 06:08:36 GMT; HttpOnly; path=/; Domain=.breyanzihcp.com
set-cookie: incap_ses_210_2628109=eXNTcl3Udj/8KrcSGxLqAiU6c2EAAAAAMQvpTKt17YG9F0YX5/vXFg==; path=/; Domain=.breyanzihcp.com
x-cdn: Imperva
x-iinfo: 10-52717788-52717791 NNNN CT(39 69 0) RT(1634941476789 0) q(0 0 1 1) r(5 5) U6

breyanzihcp.com Whois Information

Domain Name: BREYANZIHCP.COM
Registry Domain ID: 2309120077_DOMAIN_COM-VRSN
Registrar WHOIS Server: whois.corporatedomains.com
Registrar URL: http://cscdbs.com
Updated Date: 2021-08-10T12:36:36Z
Creation Date: 2018-09-12T17:17:45Z
Registry Expiry Date: 2022-09-12T17:17:45Z
Registrar: CSC Corporate Domains, Inc.
Registrar IANA ID: 299
Registrar Abuse Contact Email: domainabuse@cscglobal.com
Registrar Abuse Contact Phone: 8887802723
Domain Status: clientTransferProhibited https://icann.org/epp#clientTransferProhibited
Name Server: NS-1163.AWSDNS-17.ORG
Name Server: NS-1652.AWSDNS-14.CO.UK
Name Server: NS-376.AWSDNS-47.COM
Name Server: NS-668.AWSDNS-19.NET
DNSSEC: unsigned
>>> Last update of whois database: 2021-09-11T11:36:21Z <<<

breyanzihcp.com valuation and analysis